This segment focuses on the research, development, manufacturing, and commercialization of traditional Chinese medicines (TCM). R&D activities include the extraction, purification, and formulation of herbal ingredients, as well as the development of new TCM products based on traditional knowledge and modern scientific methods. Technologies used involve advanced extraction techniques, quality control systems, and modern pharmaceutical manufacturing processes. The therapeutic areas covered include a wide range of conditions, such as respiratory illnesses, cardiovascular diseases, and digestive disorders. The company aims to improve patient outcomes by providing effective and safe TCM products, leveraging its strong brand recognition and distribution network in China. Future opportunities lie in expanding the product portfolio, exploring international markets, and integrating TCM with modern medicine. Regulatory aspects involve compliance with Chinese Pharmacopoeia standards and obtaining necessary approvals for product registration and marketing. Partnerships may include collaborations with TCM research institutions and hospitals.

This segment encompasses the manufacture and sale of chemical raw materials, preparations, and nutritional and health products. Research and development efforts focus on the synthesis of active pharmaceutical ingredients (APIs), formulation development, and the creation of new drug delivery systems. Technologies employed include chemical synthesis, analytical testing, and modern pharmaceutical manufacturing processes. The therapeutic areas covered include a broad spectrum of diseases, such as cardiovascular diseases, diabetes, and infectious diseases. The company aims to improve patient outcomes by providing high-quality, affordable Western medicines. Market positioning is based on a strong presence in the Chinese market and competitive pricing. Future opportunities include expanding the product portfolio, entering new therapeutic areas, and exploring international markets. Regulatory aspects involve compliance with Chinese and international pharmaceutical regulations, including obtaining necessary approvals for product registration and marketing. Partnerships may include collaborations with international pharmaceutical companies and research institutions.